GLP-1s lower risk of 10 obesity-associated cancers, study shows

Research finds GLP-1s are more effective in mitigating the risk of 10 obesity-related cancers than their type 2 diabetes drug alternatives.

July 5, 2024 Check out STAT+

Sponsored By

Adobe STAT+ | GLP-1s lower risk of 10 obesity-associated cancers, study shows The retrospective study, published Friday, found that GLP-1s better mitigated the risk of 10 obesity-associated cancers than diabetes drug alternatives. By Rohan Rajeev STAT+ | Judge rules against Boehringer Ingelheim in pharma's latest legal loss on Medicare negotiation Boehringer Ingelheim, which makes Jardiance, lost a court case challenging the constitutionality of Medicare's drug price negotiation program. By Rachel Cohrs Zhang STAT+ | AbbVie dramatically outspent its pharma company rivals in 2023 to promote its drugs to doctors The total is the largest amount spent on doctor marketing and promotion since federal Open Payments data became available. By Nicholas Florko and J. Emory Parker Adobe Opinion: My stalled relay race to get access to ALS drugs in development Trying to get access to drugs in development for ALS through the FDA's expanded access program has been like a terribly uneven relay race. By Lynn Brielmaier STAT+ | U.K. trade group scolds Novo, Novartis, Pfizer, and Otsuka for violating industry codes The reprimands arrive as the U.K.'s Prescription Medicines Code of Practice Authority is under scrutiny for its oversight of drug companies. By Ed Silverman Constructing an atlas of human biology in space: Q&A with Christopher Mason Q&A with Christopher Mason of Weill Cornell Medicine on new atlas of "space omics," the study of the physiological impact of spaceflight on humans. By Nicholas St. Fleur

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser